GIANNONE, FERDINANDO ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 1.607
EU - Europa 1.052
AS - Asia 479
AF - Africa 58
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.201
Nazione #
US - Stati Uniti d'America 1.602
GB - Regno Unito 300
VN - Vietnam 241
SE - Svezia 171
IT - Italia 157
CN - Cina 136
DE - Germania 123
IN - India 58
CH - Svizzera 54
IE - Irlanda 50
RU - Federazione Russa 39
UA - Ucraina 39
FR - Francia 35
TG - Togo 27
EE - Estonia 22
JO - Giordania 22
ZA - Sudafrica 22
BG - Bulgaria 21
IR - Iran 12
BE - Belgio 11
FI - Finlandia 8
HR - Croazia 8
CI - Costa d'Avorio 6
CA - Canada 5
NL - Olanda 5
JP - Giappone 3
BR - Brasile 2
ES - Italia 2
GR - Grecia 2
NG - Nigeria 2
RO - Romania 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
CL - Cile 1
HK - Hong Kong 1
IL - Israele 1
LB - Libano 1
NO - Norvegia 1
SC - Seychelles 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.201
Città #
Southend 274
Fairfield 223
Chandler 189
Dong Ket 165
Woodbridge 127
Ashburn 126
Wilmington 99
Seattle 97
Cambridge 94
Houston 88
Ann Arbor 72
Bologna 63
Princeton 62
Dublin 50
Bern 48
Lomé 27
Westminster 27
Amman 22
Nanjing 22
Padova 22
San Diego 20
Sofia 20
Shenyang 19
Jacksonville 17
Jinan 17
Turin 16
Berlin 15
New York 14
Bremen 12
Hebei 12
Brussels 11
Redmond 11
Saint Petersburg 11
Beijing 10
Florence 10
Boardman 7
Changsha 7
Helsinki 7
Tianjin 7
Abidjan 6
Ardabil 6
Des Moines 6
Nanchang 6
Ningbo 6
Chicago 5
Jiaxing 5
Olalla 5
Redwood City 5
Amsterdam 4
Dearborn 4
Mountain View 4
Mülheim 4
Norwalk 4
Guangzhou 3
Haikou 3
Lausanne 3
Medford 3
Milan 3
San Jose 3
Toronto 3
Zhengzhou 3
Aachen 2
Abeokuta 2
Barcelona 2
Bühl 2
Dallas 2
Esslingen am Neckar 2
Kuban 2
Lanzhou 2
London 2
Paris 2
Phoenix 2
San Francisco 2
Singapore 2
São Paulo 2
Taizhou 2
Verona 2
Zanjan 2
Andover 1
Azor 1
Bangkok 1
Baranzate 1
Casamassima 1
Catania 1
Chongqing 1
Civitavecchia 1
Costa Mesa 1
Cupertino 1
Ferrara 1
Forlì 1
Frankfurt Am Main 1
Fremont 1
Gambettola 1
Gatteo 1
Groningen 1
Hangzhou 1
Hefei 1
Hong Kong 1
Kiev 1
Kilburn 1
Totale 2.290
Nome #
A novel model of CCl4-induced cirrosi with ascites in the mouse. 175
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 166
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 163
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate 147
Androgen receptor expression in the human vagina under different physiological and treatment conditions 139
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 137
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 136
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 131
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 126
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 124
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 120
The analysis of food intake in patients with cirrhosis waiting for liver transplantation: A neglected step in the nutritional assessment 119
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 118
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 115
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 113
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma 111
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 109
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 102
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 102
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 100
The role of the endocannabinoid system in liver diseases. 98
null 98
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 92
Portal hypertension and liver cirrhosis in rats: effect of the beta3-adrenoceptor agonist SR58611A. 85
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1-receptor in a rat model of CCl4-induced advanced cirrhosis. 85
Effetto dell’antagonismo farmacologico dei recettori per gli endocannabinoidi sull’equilibrio idrosodico nella cirrosi epatica. Prospettive terapeutiche. [Effect of the pharmacological antagonism of the endocannabinoid receptors on the sodium balance in liver cirrhosis] 82
Response to The reduced CO2+ -binding ability of ischaemia-modified albumin is unlikely to be because of oxidative modification of the N-terminus" 76
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 74
Adjuvant beverage - Valutazione della distensione intestinale, preliminare alla Entero-RM, mediante un prodotto naturale 55
Totale 3.298
Categoria #
all - tutte 7.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201954 0 0 0 0 0 0 0 0 0 0 15 39
2019/2020857 104 23 4 40 84 86 114 115 136 68 31 52
2020/2021552 85 34 4 21 9 37 15 26 41 23 28 229
2021/2022705 91 17 46 75 45 27 22 60 18 42 168 94
2022/2023727 73 106 50 88 48 58 12 26 115 21 56 74
2023/2024188 25 33 6 35 16 35 16 7 5 10 0 0
Totale 3.298